UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000002763
Receipt No. R000003129
Scientific Title Phase II study of Amrubicin in patients with Small-Cell Lung Cancer that is refractory or relapsed within 90 days of completing previous treatment (JCOG0901)
Date of disclosure of the study information 2009/11/13
Last modified on 2014/02/21 14:31:17

No. Disposal Last modified on Item of update
1 Insert 2009/11/13 13:34:56
2 Update 2010/06/04 14:32:49 Name of person sending information
Name of person sending information
3 Update 2010/06/04 14:34:06 Key inclusion criteria
4 Update 2010/12/09 11:19:23 Institutions
5 Update 2011/08/03 12:47:25 Recruitment status
Last follow-up date
6 Update 2013/03/26 17:15:43 Post marketing survey by drug manufacture etc., specified by Japanese law.
7 Update 2013/07/29 16:54:46 Recruitment status
Date analysis concluded
8 Update 2014/02/21 14:31:17 Publication of results
URL related to results and publications

Contact us.